Eton Pharmaceuticals, Inc. ETON Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | -$3.82M-308% | -$936K— | —— | ||
| $4.04M+253% | $1.15M+27.2% | $901K-49.2% | $1.77M+284% | ||
| $5.51M+74.2% | $3.17M+0.9% | $3.14M-25.6% | $4.22M+24.8% | ||
| —— | —— | $6.82M— | —— | ||
| $333K— | —— | $0-100% | $38K— | ||
| $0-100% | $30M— | $0— | $0— | ||
| -$333K— | —— | -$775K+72.2% | -$2.79M— | ||
| —— | $32.59M+3,506% | -$957K— | —— | ||
| —— | —— | —— | $1.9M+128% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Eton Pharmaceuticals, Inc. generate?
- Eton Pharmaceuticals, Inc. (ETON) generated $29.5M in operating cash flow over the trailing twelve months.
- What is Eton Pharmaceuticals, Inc.'s free cash flow?
- After $408.0K of capital expenditures, Eton Pharmaceuticals, Inc.'s free cash flow was $29.1M over the trailing twelve months, up 1588.2% year over year.
- Where does Eton Pharmaceuticals, Inc.'s cash flow data come from?
- Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
